Although these studies provided evidence to separate EBV+ NT/NKCL from ENKTL and PTCL-NOS, the JAK/STAT signal pathway mutation profile overlaps with that of ALK-negative ALCL [20]. The gene discussed is SOAT1; the disease is anaplastic large cell lymphoma.